E3 ubiquitin ligase RNF6 promotes antiviral immune responses through enhancing the expression of interferon stimulated genes in myeloid cells

Clin Immunol. 2022 Sep:242:109099. doi: 10.1016/j.clim.2022.109099. Epub 2022 Aug 13.

Abstract

Interferon signaling is closely associated with clearance of viral infections as well as the development of systemic lupus erythematosus (SLE). Therefore, from a clinical perspective, it is important to identify the key regulators involved in interferon signaling pathways. In this study, we identified that RNF6, as an interferon inducible E3 ubiquitin ligase, promoted the interferon-dependent antiviral response. Knock-down of RNF6 greatly attenuated expression of ISGs and the transcriptional activity of ISRE. Specifically, increased RNF6 expression in myeloid cells of patients with SLE correlated with high expression of ISGs. Our results uncover RNF6 as a positive mediator in the antiviral immune responses and suggest that RNF6 may contribute to predict interferon signaling in SLE.

Keywords: Innate immunity; Myeloid cell; RNF6; Systemic lupus erythematosus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents
  • DNA-Binding Proteins / genetics
  • Humans
  • Immunity
  • Interferons
  • Lupus Erythematosus, Systemic*
  • Myeloid Cells / metabolism
  • Ubiquitin-Protein Ligases* / genetics

Substances

  • Antiviral Agents
  • DNA-Binding Proteins
  • RNF6 protein, human
  • Interferons
  • Ubiquitin-Protein Ligases